In May 2023, Imexpharm Pharmaceutical Joint Stock Company hosted experts from the Hungarian Ministry of Health, conducting a periodic reassessment and reaffirmed that the pharmaceutical production lines at the IMP2 factory (Vinh Loc Industrial Park, Ho Chi Minh City) and the IMP3 cluster (VSIP II Industrial Park, Binh Duong Province) consistently meet EU-GMP principles and standards in pharmaceutical manufacturing.
The company headquarters of Imexpharm is located in Dong Thap Province.
Imexpharm is currently one of the leaders in Vietnam in terms of the number of pharmaceutical production lines certified to EU-GMP standards. The meeting with the Hungarian Ministry of Health reinforced Imexpharm's manufacturing capabilities in producing European-standard medicines right in Vietnam.
People's Doctor, Pharmacist Tran Thi Dao and General Director of Imexpharm, stated: "We have consistently maintained an internationally standardized production system aligned with Imexpharm’s development orientation for more than 20 years. This commitment is embodied in our mission to 'Enhance quality of life by concentrating resources and investing systematically in EU-GMP-certified factories to provide high-quality, effective, and reasonably priced medicines to every patient.'"
EU-GMP (Good Manufacturing Practices - European Union) represents one of the highest quality standards, as detailed in Volume 4 of the EU’s guidelines for the manufacture of advanced therapy medicinal products (ATMPs). Key areas assessed under EU-GMP include personnel, facilities, production equipment, quality control systems, EU-GMP-compliant documentation, raw materials, and internal audits conducted within enterprises.
The IMP4 factory meets EU-GMP standards
Imexpharm, headquartered in Dong Thap Province, operates 20 sales branches across Vietnam. The company currently owns 11 EU-GMP-certified production lines across three factory clusters: IMP2 Factory: High-tech antibiotic factory at Vinh Loc Industrial Park; IMP3 Cluster: Penicillin and Cephalosporin factories located in Binh Duong Province; IMP4 Factory: High-tech facility in Binh Duong.
Personnel working in an EU-GMP-certified factory
With over 45 years of establishment and development, Imexpharm is dedicated to improving product quality, upgrading technology, and modernizing production infrastructure. This approach aims to provide the market with Vietnamese pharmaceutical products under the Imexpharm brand that meet European quality standards.
The company emphasizes its commitment to international standards through continuous adoption of advanced scientific and technical advancements in production, upgrading equipment and processes, and adhering to environmental protection regulations and social responsibilities.
Aspiring to provide high-efficiency health solutions for the community, Imexpharm is determined to become the leading antibiotic manufacturer in Vietnam in the coming years. "This is the message of ‘Confident Breakthrough,’ shared by our investors, partners, and shareholders during the recent Annual General Meeting," said an Imexpharm representative.
Thanh Hoa - vnexpress.vn